Cargando…

Disease modeling and stem cell immunoengineering in regenerative medicine using CRISPR/Cas9 systems

CRISPR/Cas systems are popular genome editing tools that belong to a class of programmable nucleases and have enabled tremendous progress in the field of regenerative medicine. We here outline the structural and molecular frameworks of the well-characterized type II CRISPR system and several computa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Antao, Ainsley Mike, Karapurkar, Janardhan Keshav, Lee, Dong Ryul, Kim, Kye-Seong, Ramakrishna, Suresh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Research Network of Computational and Structural Biotechnology 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710510/ https://www.ncbi.nlm.nih.gov/pubmed/33304462 http://dx.doi.org/10.1016/j.csbj.2020.11.026

Ejemplares similares

Ubiquitin-Specific Protease 3 Deubiquitinates and Stabilizes Oct4 Protein in Human Embryonic Stem Cells
por: Rhie, Byung-Ho, et al.
Publicado: (2021)

Genome-Wide CRISPR/Cas9-Based Screening for Deubiquitinase Subfamily Identifies Ubiquitin-Specific Protease 11 as a Novel Regulator of Osteogenic Differentiation
por: Kaushal, Kamini, et al.
Publicado: (2022)

CRISPR/Cas9-based genome-wide screening of the deubiquitinase subfamily identifies USP3 as a protein stabilizer of REST blocking neuronal differentiation and promotes neuroblastoma tumorigenesis
por: Karapurkar, Janardhan Keshav, et al.
Publicado: (2023)

The Role of Nkx3.1 in Cancers and Stemness
por: Antao, Ainsley Mike, et al.
Publicado: (2021)

The Role of Deubiquitinating Enzymes in Hematopoiesis and Hematological Malignancies
por: Sarodaya, Neha, et al.
Publicado: (2020)

Advances in Deubiquitinating Enzyme Inhibition and Applications in Cancer Therapeutics
por: Antao, Ainsley Mike, et al.
Publicado: (2020)

Genome-wide screening for deubiquitinase subfamily identifies ubiquitin-specific protease 49 as a novel regulator of odontogenesis
por: Kaushal, Kamini, et al.
Publicado: (2022)

Phage engineering and phage‐assisted CRISPR‐Cas delivery to combat multidrug‐resistant pathogens
por: Khambhati, Khushal, et al.
Publicado: (2022)

Gene delivery for immunoengineering
por: Neshat, Sarah Y, et al.
Publicado: (2020)

CRISPR/Cas9 Immunoengineering of Hoxb8-Immortalized Progenitor Cells for Revealing CCR7-Mediated Dendritic Cell Signaling and Migration Mechanisms in vivo
por: Hammerschmidt, Swantje I., et al.
Publicado: (2018)

T cell immunoengineering with advanced biomaterials
por: Delcassian, Derfogail, et al.
Publicado: (2017)

Oral drug delivery for immunoengineering
por: Le, Tien, et al.
Publicado: (2021)

Immunoengineered MXene nanosystem for mitigation of alloantigen presentation and prevention of transplant vasculopathy
por: Yan, Weiang, et al.
Publicado: (2023)

USP48 Governs Cell Cycle Progression by Regulating the Protein Level of Aurora B
por: Antao, Ainsley Mike, et al.
Publicado: (2021)

Freeze-drying for the preservation of immunoengineering products
por: Kommineni, Nagavendra, et al.
Publicado: (2022)

Nanoparticle-Based Immunoengineered Approaches for Combating HIV
por: Bowen, Allan, et al.
Publicado: (2020)

The sixth revolution in pediatric vaccinology: immunoengineering and delivery systems
por: Soni, Dheeraj, et al.
Publicado: (2020)

Immunoengineered adjuvants for universal vaccines against respiratory viruses
por: Wang, Ji, et al.
Publicado: (2021)

Nanotechnology-enabled immunoengineering approaches to advance therapeutic applications
por: Chuang, Skylar T., et al.
Publicado: (2022)

Scaffold-Mediated Immunoengineering as Innovative Strategy for Tendon Regeneration
por: Russo, Valentina, et al.
Publicado: (2022)

Bioactive Lipid O-cyclic phytosphingosine-1-phosphate Promotes Differentiation of Human Embryonic Stem Cells into Cardiomyocytes via ALK3/BMPR Signaling
por: Jang, Ji-Hye, et al.
Publicado: (2021)

E3 Ubiquitin Ligase APC/C(Cdh1) Regulation of Phenylalanine Hydroxylase Stability and Function
por: Tyagi, Apoorvi, et al.
Publicado: (2020)

CRISPR/Cas9-based genome-wide screening for deubiquitinase subfamily identifies USP1 regulating MAST1-driven cisplatin-resistance in cancer cells
por: Tyagi, Apoorvi, et al.
Publicado: (2022)

Biomaterial-based immunoengineering to fight COVID-19 and infectious diseases
por: Zarubova, Jana, et al.
Publicado: (2021)

Progress and Perspective of CRISPR‐Cas9 Technology in Translational Medicine
por: Zheng, Ruixuan, et al.
Publicado: (2023)

What is CRISPR/Cas9?
por: Redman, Melody, et al.
Publicado: (2016)

Advances in CRISPR/Cas9
por: Zhu, Youmin
Publicado: (2022)

Sperm protein 17 targeting for epithelialovarian cancer treatment in the eraof modern immunoengineering
por: Poplawska, Maria, et al.
Publicado: (2021)

Immunoengineering via Chimeric Antigen Receptor-T Cell Therapy: Reprogramming Nanodrug Delivery
por: Katopodi, Theodora, et al.
Publicado: (2023)

The Advance of CRISPR-Cas9-Based and NIR/CRISPR-Cas9-Based Imaging System
por: Qiao, Huanhuan, et al.
Publicado: (2021)

CRISPR/Cas9-Targeted Mutagenesis in Caenorhabditis elegans
por: Waaijers, Selma, et al.
Publicado: (2013)

Immunoengineered magnetic-quantum dot nanobead system for the isolation and detection of circulating tumor cells
por: Zhang, Pengfei, et al.
Publicado: (2021)

CRISPR/Cas9 assisted stem cell therapy in Parkinson's disease
por: Pinjala, Poojitha, et al.
Publicado: (2023)

Efficient Mitochondrial Genome Editing by CRISPR/Cas9
por: Jo, Areum, et al.
Publicado: (2015)

CRISPR/Cas9 in Gastrointestinal Malignancies
por: Jefremow, André, et al.
Publicado: (2021)

Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
por: Zhang, Song, et al.
Publicado: (2021)

A CRISPR-Cas9-mediated F0 screen to identify pro-regenerative genes in the zebrafish retinal pigment epithelium
por: Lu, Fangfang, et al.
Publicado: (2023)

The MyLO CRISPR-Cas9 toolkit: a markerless yeast localization and overexpression CRISPR-Cas9 toolkit
por: Bean, Björn D M, et al.
Publicado: (2022)

CRISPR/Cas9 and Nanotechnology Pertinence in Agricultural Crop Refinement
por: Naik, Banavath Jayanna, et al.
Publicado: (2022)

Application of CRISPR/Cas9 Technology to HBV
por: Lin, Guigao, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_b3317jth4ehnebgjuedat8amth